Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Savolitinib
Study Purpose: This study was done in healthy male
participants to learn how savolitinib
passes through, breaks down, and leaves
the body
Protocol Number: D5084C00010
Thank you!
Thank you for taking part in the clinical study for the study drug savolitinib, also
called AZD6094.
AstraZeneca AB sponsored this study and believes it is important to share the
results. An independent non-profit organization called CISCRP helped prepare this
summary of the study results for you.
If you participated in the study and have questions about the results, please speak
with the study doctor or staff at your study site.
1